AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8523654
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no PGE1 administration)
Trial: 6218964
Drug: Depo-medroxyprogesterone acetate
RxNorm normalized name: medroxyprogesterone Injection [Depo-Provera]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 5
Trial: 6218964
Drug: Depo-medroxyprogesterone acetate
RxNorm normalized name: medroxyprogesterone Injection [Depo-Provera]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 7
Trial: 6218964
Drug: Depo-medroxyprogesterone acetate
RxNorm normalized name: medroxyprogesterone Injection [Depo-Provera]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 9
Trial: 6218964
Drug: Depo-medroxyprogesterone acetate
RxNorm normalized name: medroxyprogesterone Injection [Depo-Provera]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depo-medroxyprogesterone acetate (DMPA) administered on cycle day 11
Trial: 25500669
Drug: Vapor ablation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vapor ablation therapy targeting the most diseased segments of the lung, specific dosage and duration not mentioned.
Trial: 22840278
Drug: C+P (behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C+P (behavioral counseling and education followed by monthly phone calls for 6 months)
Trial: 17664469
Drug: ECF (epirubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ECF (epirubicin 50 mg/m(2) on day 1, cisplatin 60 mg/m(2) on day 1, and fluorouracil 200 mg/m(2)/d on days 1 to 21)
Trial: 17664469
Drug: TC (docetaxel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TC (docetaxel initially 85 mg/m(2) on day 1, later reduced to 75 mg/m(2), and cisplatin 75 mg/m(2) on day 1)
Trial: 17664469
Drug: TCF (TC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TCF (TC plus FU 300 mg/m(2)/d on days 1 to 14)
Trial: 2246915
Drug: Low-dose sotalol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sotalol (40 mg every 8 hours)
Trial: 2246915
Drug: Low-dose propranolol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose propranolol (10 mg every 6 hours)
Trial: 2246915
Drug: High-dose sotalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sotalol (80 mg every 8 hours)
Trial: 2246915
Drug: High-dose propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose propranolol (20 mg every 6 hours)
Trial: 2246915
Drug: High-dose sotalol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose sotalol
Trial: 2246915
Drug: Low-dose propranolol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose propranolol
Trial: 2246915
Drug: High-dose propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose propranolol
Trial: 6818684
Drug: Ordinary cow
RxNorm normalized name: Cow milk
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary cow milk (lactose content, 25 g)
Trial: 29092881
Drug: Potassium chloride
RxNorm normalized name: Potassium Chloride
DrugBank: Potassium chloride (DB00761)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium chloride (KCl) supplements, 40 mEq/d for 3 months
Trial: 24922046
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of rosuvastatin for 6 weeks before carotid artery stenting (CAS)
Trial: 18258584
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care and rinses
Trial: 12805333
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy (HDT) with autologous stem-cell transplantation (ASCT)
Trial: 11205467
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy (HDT) with ASCT (in patients < 65 years)
Trial: 11205467
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (in patients < 65 years)
Trial: 9084194
Drug: Topical doxymycine
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical doxymycine
Trial: 8366182
Drug: Didanosine 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine 300 mg chewable tablet after overnight fast
Trial: 8366182
Drug: Didanosine 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine 300 mg chewable tablet 30 minutes before a meal
Trial: 8366182
Drug: Didanosine 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine 300 mg chewable tablet 1 hour before a meal
Trial: 8366182
Drug: Didanosine 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine 300 mg chewable tablet 1 hour after a meal
Trial: 8366182
Drug: Didanosine 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine 300 mg chewable tablet 2 hours after a meal
Trial: 30647044
Drug: BDD-NET (therapist-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDD-NET (therapist-guided internet-based cognitive behavioural therapy)
Trial: 28306389
Drug: Inclisiran (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inclisiran (200 mg, 300 mg, 500 mg single dose)
Trial: 28306389
Drug: Inclisiran (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inclisiran (100 mg, 200 mg, 300 mg two doses at days 1 and 90)
Trial: 28306389
Drug: Inclisiran (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inclisiran (300 mg two doses)
Trial: 25326088
Drug: Guidelines on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guidelines on treatment of RTIs and uncomplicated lower UTIs with sustained, regular feedback on individual antibiotic prescription behaviour during 2 years
Trial: 22965965
Drug: Cediranib 20
RxNorm normalized name: cediranib
DrugBank: Cediranib (DB04849)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cediranib 20 mg plus FOLFOX/CAPOX
Trial: 19006537
Drug: Lubiprostone 8
RxNorm normalized name: LUBIPROSTONE 8MCG CAP,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone 8 mcg twice daily
Trial: 2825469
Drug: Naloxone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (6 mg/kg)
Trial: 29292242
Drug: ticagrelor 90
RxNorm normalized name: ticagrelor 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ticagrelor 90 mg twice daily
Trial: 29292242
Drug: prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: prasugrel 10 mg once daily
Trial: 23963690
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) soybean, olive oil, and fish oil emulsion
Trial: 23963690
Drug: Parenteral soybean
RxNorm normalized name: SOYBEAN
DrugBank: Soybean (DB10568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral soybean and olive oil emulsion (control)
Trial: 22390886
Drug: Internet-delivered physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered physical activity and healthy nutrition program with monthly email messages and additional web-based tools.
Trial: 22390886
Drug: Monthly email
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly email messages to promote website visits during the first year.
Trial: 20869041
Drug: 20-week treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 20-week treatment for BED
Trial: 16027343
Drug: Injected hyaluronidase
RxNorm normalized name: hyaluronidase Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injected hyaluronidase (3 different doses)
Trial: 30516416
Drug: Daily text
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily text message reminders (N = 42)
Trial: 30516416
Drug: Weekly text
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly text message reminders (N = 37)
Trial: 27040362
Drug: Low non-HDL-C
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low non-HDL-C level (≤140 mg/dl)
Trial: 27040362
Drug: Low cholesterol
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low cholesterol group (≤140 mg/dl)
Trial: 25130584
Drug: Tadalafil (phosphodiesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil (phosphodiesterase enzyme-5 inhibitor)
Trial: 15860392
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg/day for 3 days
Trial: 11939924
Drug: Ropivacaine 2
RxNorm normalized name: fentanyl-ropivacaine 2 mcg/mL-0.1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2 mg/mL with sufentanil 0.75 microg/mL
Trial: 11939924
Drug: Bupivacaine 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 1.25 mg/mL with sufentanil 0.75 microg/mL
Trial: 2572140
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cetirizine nocte
Trial: 2572140
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg terfenadine given morning and evening
Trial: 1096829
Drug: Agar (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agar (600 mg/kg daily for 7 days, starting at 12 hours of age)
Trial: 1096829
Drug: Agar (700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agar (700 mg/kg daily for 7 days, starting at 6 hours of age)
Trial: 28851329
Drug: Additional daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional daily school-time physical activity (PA)
Trial: 25344064
Drug: Intravenous dantrolene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dantrolene (IV‐D) 1.25 mg every 6 hours for 7 days (n=16)
Trial: 20110024
Drug: Etizolam 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etizolam 0.5 mg BID
Trial: 17007849
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg anastrozole for 5 days (cycle days 3‐7) followed by FSH injections (days 7‐11)
Trial: 17007849
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg clomiphene citrate for 5 days (cycle days 3‐7) followed by FSH injections (days 7‐11)
Trial: 17007849
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg clomiphene citrate
Trial: 15503077
Drug: Total daily
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total daily energy expenditure (TEE)
Trial: 10709155
Drug: Cetrorelix (CET)
RxNorm normalized name: Cetrorelix
DrugBank: Cetrorelix (DB00050)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetrorelix (CET) 3 mg intravenously (IV)
Trial: 10709155
Drug: Cetrorelix (CET)
RxNorm normalized name: Cetrorelix
DrugBank: Cetrorelix (DB00050)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetrorelix (CET) 3 mg subcutaneously (SC)
Trial: 10709155
Drug: Cetrorelix (CET)
RxNorm normalized name: Cetrorelix
DrugBank: Cetrorelix (DB00050)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetrorelix (CET) 3 mg IV
Trial: 10709155
Drug: Cetrorelix (CET)
RxNorm normalized name: Cetrorelix
DrugBank: Cetrorelix (DB00050)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetrorelix (CET) 3 mg SC
Trial: 10709155
Drug: Cetrorelix (CET)
RxNorm normalized name: Cetrorelix
DrugBank: Cetrorelix (DB00050)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cetrorelix (CET) 3 mg IV and SC
Trial: 1547881
Drug: Single-agent interferon
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent interferon (IFN)-alpha at an initial dose of 4 x 10(6) U/m2 (arm A)
Trial: 1547881
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IFN-alpha and low-dose IFN-gamma (arm B)
Trial: 28586116
Drug: Fecal microbiota
RxNorm normalized name: Fecal Microbiota
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fecal microbiota transplant (FMT) with 5 days of broad-spectrum antibiotic pretreatment and a single FMT enema from the same donor.
Trial: 18444793
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of metronidazole plus 150 mg of fluconazole
Trial: 14979636
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (200 mg for children ≤ 7 years, 290 mg for children > 7 years)
Trial: 14979636
Drug: Placebo (260
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (260 mg glucose)
Trial: 10907966
Drug: Heparin (30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (30, 60, 120, or 240 U/kg bolus)
Trial: 10907966
Drug: Heparin (0.15,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (0.15, 0.20, 0.25, or 0.30 U/kg/minute with or without a 125-U/kg bolus)
Trial: 10907966
Drug: Argatroban (250-microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argatroban (250-microg/kg bolus plus infusion of 15, 20, 30, and 40 microg/kg/minute)
Trial: 8698954
Drug: Naltrexone (opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (opioid receptor blockade)
Trial: 4005391
Drug: Furosemide 40
RxNorm normalized name: furosemide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 40 mg (repeated dose)
Trial: 31087536
Drug: Fluconazole with
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole with a loading dose of 25 mg/kg
Trial: 31087536
Drug: Fluconazole without
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole without specified loading dose
Trial: 30336850
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine (1.5 mg kg-1 then 4 mg kg-1 h-1)
Trial: 30336850
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine and saline
Trial: 27615041
Drug: Inhalation breathing
RxNorm normalized name: beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation breathing exercises using incentive spirometry (Control)
Trial: 22309470
Drug: Contingency management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contingency management in combination with family engagement strategies (CM-FAM)
Trial: 12404080
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (NRT) patches (21 mg/24 h)
Trial: 12404080
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (NRT) patches
Trial: 9454908
Drug: L-arginine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (30 g/day for three days)
Trial: 1710743
Drug: Bezafibrate (Bezalip
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bezafibrate (Bezalip Mono) 400 mg once daily
Trial: 29743827
Drug: Carbohydrate mouth
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate mouth rinse (CMR) with a 6% unflavored maltodextrin solution
Trial: 26246020
Drug: Polysoft patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polysoft patch (PP)
Trial: 26246020
Drug: Modified Kugel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Kugel patch (MK)
Trial: 22892729
Drug: 1-visit treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-visit treatment
Trial: 22892729
Drug: 2-visit treatment
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 2-visit treatment
Trial: 15842552
Drug: Gentamicin delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin delivered orally (80 mg)
Trial: 15842552
Drug: Gentamicin delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin delivered intravenously (40 mg)
Trial: 15842552
Drug: Aerodynamic characteristics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerodynamic characteristics of nebulized doses from PARI
Trial: 15842552
Drug: Aerodynamic characteristics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerodynamic characteristics of nebulized doses from MN
Trial: 11932273
Drug: E/A group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E/A group (1.25 mg estrogen + 2.5 mg methyltestosterone/d)
Trial: 11932273
Drug: E group
RxNorm normalized name: MENINGOCOCCAL OLIGOSACCHARIDE VACCINE GROUP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E group (1.25 mg/d)
Trial: 3276201
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of estradiol valerate topical gel
Trial: 3276201
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of prostaglandin E2 gel
Trial: 3276201
Drug: Placebo prostaglandin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo prostaglandin E2 dosage
Trial: 25001158
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of 0.5 mg bevacizumab
Trial: 26644132
Drug: Reinforcement‐based Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinforcement‐based Treatment plus Women's Co‐Op (RBT + WC)
Trial: 20140405
Drug: Cognitive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive treatment of illness perceptions
Trial: 18542921
Drug: High volume
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High volume hemofiltration (HVHF 65 ml/(kg h))
Trial: 18542921
Drug: Low volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low volume hemofiltration (LVHF 35 ml/(kg h))
Trial: 9537146
Drug: Topical anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anaesthesia with a van Lint block
Trial: 19938160
Drug: CC genotype
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC genotype
Trial: 22353457
Drug: Glass ionomer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glass ionomer sealants with tooth preparation
Trial: 22353457
Drug: Resin sealants
RxNorm normalized name: Benzoin resin
DrugBank: Benzoin resin (DB11222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resin sealants with tooth preparation
Trial: 22353457
Drug: Glass ionomer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glass ionomer sealants without tooth preparation
Trial: 22353457
Drug: Resin sealants
RxNorm normalized name: Benzoin resin
DrugBank: Benzoin resin (DB11222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resin sealants without tooth preparation
Trial: 22353457
Drug: Tooth preparation
RxNorm normalized name: porcine tooth preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tooth preparation
Trial: 22353457
Drug: Glass ionomer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glass ionomer sealants without preparation
Trial: 16076991
Drug: High dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dairy diet (1200 mg Ca/d, 3 servings of dairy)
Trial: 16076991
Drug: Low dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dairy diet (500 mg/d, <1 serving/d)
Trial: 16076991
Drug: High dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dairy diet (1200 mg Ca/d, 3 servings of dairy) with caloric restriction (‐500 kcal/d)
Trial: 16076991
Drug: Low dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dairy diet (500 mg/d, <1 serving/d) with caloric restriction (‐500 kcal/d)
Trial: 12242580
Drug: Pramipexole 0.27
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole 0.27 mg
Trial: 10224181
Drug: Surfactant lavage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surfactant lavage with 15 mL/kg of diluted surfactant solution (Survanta) at a phospholipid concentration of 5 mg/mL administered in 2-mL aliquots
Trial: 28181920
Drug: Standard-care group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-care group (physical therapy as ordered by the primary care team)
Trial: 23714773
Drug: Atorvastatin (80‐mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80‐mg loading dose given a mean of 1.5 hours before percutaneous coronary intervention)
Trial: 22120855
Drug: Eperisone 150
RxNorm normalized name: acetaminophen / phenyltoloxamine citrate Oral Tablet [Perisine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eperisone 150 mg/day in three divided doses
Trial: 10672633
Drug: Alcohol (0.26-0.28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.26-0.28 g.kg-1)
Trial: 22986437
Drug: Linaclotide 290
RxNorm normalized name: LINACLOTIDE 290MCG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linaclotide 290 μg once daily
Trial: 3367257
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg melatonin